Skip to content

Phibro Animal Health PAHC Repayments of Long-Term Lines of Credit

Repayments of Long-Term Lines of Credit at other companies

Balchem logo
BalchemBCPC
Darling Ingredients Inc. logo
Darling Ingredients Inc.DAR

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's repayments of long-term lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's repayments of long-term lines of credit?
Phibro Animal Health (PAHC) reported repayments of long-term lines of credit of $65M in Q1 2026.
How has Phibro Animal Health's repayments of long-term lines of credit changed year-over-year?
Phibro Animal Health's repayments of long-term lines of credit decreased by 36.9% year-over-year, from $103M to $65M.
What is the long-term trend for Phibro Animal Health's repayments of long-term lines of credit?
Over 4 years (2021 to 2025), Phibro Animal Health's repayments of long-term lines of credit has grown at a 12.2% compound annual growth rate (CAGR), from $391.5M to $621M.